Comments
Loading...

Eagle Pharmaceuticals

EGRXNASDAQ
Logo brought to you by Benzinga Data
$4.28
-0.15-3.39%
At Close: -
$3.83
-0.45-10.51%
After Hours: Sep 10, 4:02 PM EDT
15 minutes delayed

Eagle Pharmaceuticals (NASDAQ:EGRX) Stock, Guidance And Forecast

Companies issue guidance, or expectations of future EPS and revenue, so investors have a sense of how much money a company will make in a future period.

Data brought to you by Benzinga APIs

FAQ

Q

What is the most recent guidance for Eagle Pharmaceuticals (EGRX)?

A

The most recent guidance for Eagle Pharmaceuticals (EGRX) was reported on September 7, 2023 for the full year 2023. The company provided earnings per share guidance in the range of $4.40 to $4.70, compared to the estimated EPS of $4.58. Additionally, Eagle Pharmaceuticals forecasted revenue between $0.00B and $0.00B for the quarter.

Browse guidance and forecast on all stocks.

People Also Watch